158
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Incidence and Risk Factors for Venous Thromboembolism Following 2462 Major Abdomino-Pelvic Surgeries in Tertiary Hospital

, , , &
Pages 135-143 | Published online: 08 Apr 2021

References

  • Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuünemann HJ; American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:7S–47S. doi:10.1378/chest.1412S3
  • Di Nisio M, van Es N, Büller HR. Deep vein thrombosis and pulmonary embolism. Lancet. 2016;388:3060–3073. doi:10.1016/S0140-6736(16)30514-1
  • Angchaisuksiri P. Venous thromboembolism in Asian unrecognised and under-treated problem? J Thromb Haemost. 2011;106:585–590. doi:10.1160/TH11-03-0184
  • Bahl V, Hu HM, Henke PK, Wakefield TW, Campbell DA, Caprini JA. A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg. 2010;251:344–350. doi:10.1097/SLA.0b013e3181b7fca6
  • Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in non-orthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:277.
  • Yhim H, Jang MJ, Bang SM, et al. Incidence of venous thromboembolism following major surgery in Korea: from the health insurance review and assessment service database. J Thromb Haemost. 2014;12:1035–1043. doi:10.1111/jth.12611
  • Wu PK, Chen CF, Chung L, Liu C, Chen WM. Population-based epidemiology of postoperative venous thromboembolism in Taiwanese patients receiving hip or knee arthroplasty without pharmacological thromboprophylaxis. Thromb Res. 2014;133:719–724. doi:10.1016/j.thromres.2014.01.039
  • Lee CH, Lin L, Cheng C, Kao Yang YH, Chen JY, Tsai L. Incidence and cumulative recurrence rates of venous thromboembolism in the Taiwanese population. J Thromb Haemost. 2010;8:1515–1523. doi:10.1111/j.1538-7836.2010.03873.x
  • Yeo DX, Junnarkar S, Balasubramaniam S, et al. Incidence of venous thromboembolism and its pharmacological prophylaxis in Asian general surgery patients: a systemic review. World J Surg. 2015;39:150–157. doi:10.1007/s00268-014-2763-0
  • Kim JW, Chun EJ, Choi SI, et al. A prospective study on the incidence of postoperative venous thromboembolism in Korean gastric cancer patients: an inquiry into the application of Western guidelines to Asian cancer patients. PLoS One. 2013;8:e61968. doi:10.1371/journal.pone.0061968
  • Sugimachi K, Tajiri H, Kinjo N, et al. Incidence and predictors of deep venous thrombosis after abdominal oncologic surgery: prospective Doppler ultrasound screening. J Surg Res. 2012;178:657–661. doi:10.1016/j.jss.2012.06.002
  • Yang SS, Choi DW, Kim SJ, Choi SH, Sohn TS, Noh JH. Incidence and risk factors for deep vein thrombosis after abdominal surgery. Korean J Vasc Endovasc Surg. 2012;28:37–42.
  • Kim IG, Kim KH, Seo HJ, et al. Deep vein thrombosis after surgery for gastrointestinal cancer: incidence and correlation with risk factors. J Korean Soc Vasc Surg. 2004;20:237–241.
  • Vachirasrisirikul S, Laohapensang K. Incidence and risk factors of venous thromboembolism following major abdominal surgery. J Med Assoc Thai. 2016;99(6):665–674.
  • Nicolaides AN, Breddin HK, Fareed J, et al. Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence. Int Angiol. 2001;20:1–37. doi:10.1177/0003319701052001S01
  • Kakkar AK, Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 5th ed. Philadelphia: Lippincott, Williams & Wilkins; 2006:1361–1367.
  • Ngoh CI, Lai HL, Angchaisuksiri P, et al. Asian venous thromboembolism guidelines: updated recommendations for the prevention of venous thromboembolism. Int Angiol. 2017;36(1):1–20. doi:10.23736/S0392-9590.16.03765-2
  • Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2):e227S–e277S. doi:10.1378/chest.11-2297
  • Braekkan SK, Mathiesen EB, Njølstad I, Wilsgaard T, Hansen JB. Hematocrit and risk of venous thromboembolism in a general population (The Tromso study). Haematologica. 2010;95:270–275. doi:10.3324/haematol.2009.008417
  • Santos MT, Valles J, Marcus AJ, et al. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment. J Clin Invest. 1991;87:571–580. doi:10.1172/JCI115032
  • Valles J, Santos MT, Aznar J, et al. Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment. Blood. 1991;78:154–162. doi:10.1182/blood.V78.1.154.154
  • Tsai AW, Cushman M, Rosamond WD, et al. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med. 2002;113:636–642. doi:10.1016/S0002-9343(02)01345-1
  • Connolly GC, Khorana AA, Kuderer NM, et al. Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy. Thromb Res. 2010;126:113–118. doi:10.1016/j.thromres.2010.05.012
  • Ho KM, Yip CB, Duff O. Reactive thrombocytosis and risk of subsequent venous thromboembolism: a cohort study. J Thromb Haemost. 2012;10:1768–1774. doi:10.1111/j.1538-7836.2012.04846.x
  • Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation. 2008;117:93–102. doi:10.1161/CIRCULATIONAHA.107.709204
  • Prandoni P, Campello E. Venous thromboembolism in cancer patients undergoing chemotherapy: risk factor and prevention. Semin Thromb Hemost. 2021. doi:10.1055/s-0040-1718927
  • Cohen AT, Katholing A, Rietbrock S, Bamber L, Martinez C. Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. Thromb Haemost. 2016;117:57–65. doi:10.1160/TH15-08-0686
  • Moore RA, Adel N, Riedel E, et al. High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis. J Clin Oncol. 2011;29:3466–3473. doi:10.1200/JCO.2011.35.5669
  • Matsuo K, Yessaian AA, Lin YG, et al. Predictive model of venous thromboembolism in endometrial cancer. Gynecol Oncol. 2013;128:544–551. doi:10.1016/j.ygyno.2012.12.014
  • Rauh-Hain JA, Hariton E, Clemmer J, et al. Incidence and effects on mortality of venous thromboembolism in elderly women with endometrial cancer. Obstet Gynecol. 2015;125:1362–1370. doi:10.1097/AOG.0000000000000866
  • Graul A, Latif N, Zhang X, et al. Incidence of venous thromboembolism by type of gynecologic malignancy and surgical modality in National Surgical Quality Improvement Program. Int J Gynecol Cancer. 2017;27:581–587. doi:10.1097/IGC.0000000000000912
  • Angchaisuksiri P, Atichartakarn V, Aryurachai K, et al. Risk factors of venous thromboembolism in Thai patients. Int J Hematol. 2007;86:397–402. doi:10.1007/BF02983995
  • Mutirangura P, Ruengsethakit C, Wongwanit C. Epidemiologic analysis of proximal deep vein thrombosis in Thai patients: malignancy, the predominant etiologic factor. Int J Angiol. 2004;13:81–83. doi:10.1007/s00547-004-1027-5
  • Shaw JR, Douketis J, Le Gal G, Carrier M. Periprocedural interruption of anticoagulation in patients with cancer‐associated venous thromboembolism: an analysis of thrombotic and bleeding outcomes. J Thromb Haemost. 2019;17:1171–1178. doi:10.1111/jth.14468
  • Heit JA, Mohr DN, Silverstein MD, et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med. 2000;160:761–768. doi:10.1001/archinte.160.6.761
  • Prandoni P, Lensing AW, Piccioli A, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood. 2002;100:3484–3488. doi:10.1182/blood-2002-01-0108
  • Kroger K, Weiland D, Ose C, et al. Risk factors for venous thromboembolic events in cancer patients. Ann Oncol. 2006;17:297–303. doi:10.1093/annonc/mdj068
  • Louzada ML, Carrier M, Lazo-Langner A, et al. Development of a clinical prediction rule for risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism. Circulation. 2012;126:448–454. doi:10.1161/CIRCULATIONAHA.111.051920
  • Shapiro R, Vogel JD, Kiran RP. Risk of postoperative venous thromboembolism after laparoscopic and open colorectal surgery: an additional benefit of the minimally invasive approach? Dis Colon Rectum. 2011;54(12):1496–1502. doi:10.1097/DCR.0b013e31823302a1
  • Leonardi MJ, McGory ML, Ko CY. The rate of bleeding complications after pharmacologic deep venous thrombosis prophylaxis: a systematic review of 33 randomized controlled trials. Arch Surg. 2006;141(8):790–797. doi:10.1001/archsurg.141.8.790